Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Submitted by
admin
on August 18, 2024 - 9:19pm
Source:
Motley Fool
News Tags:
Eli Lilly
FDA
obesity
Zepbound
Headline:
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
snippet:
Last November, Eli Lilly received FDA approval for obesity drug Zepbound.
In the second quarter, Zepbound generated over $1.2 billion in revenue!
Do Not Allow Advertisers to Use My Personal information
